3M™ Cavilon™ Non-irritant skin protection applicator, 3345P, 3 ml, 5 ST

The 3M™ Cavilon™ Non Irritant Skin Protection Applicator (3345P) provides a safe and effective solution to protect the skin from urine, faeces, body fluids and friction. It is ideal for use on patients with sensitive or damaged skin.

3M™ Cavilon™ Non Irritant Skin Protector is the original, alcohol-free, liquid barrier film that dries quickly to form a breathable, transparent protective film on the skin, designed to protect intact, compromised or damaged skin from urine, faeces, other body fluids and skin trauma from medical adhesives (MARSI) and friction. Protects for up to 72 hours¹ ² and is non-irritating when applied to damaged skin.

Properties

• Dries quickly and is non-sticky for easy application and to improve patient comfort⁵
• Alcohol-free, does not sting even on irritated, damaged skin
• Safe; does not impair the healing process of irritated, damaged skin³ ⁴
• Barrier against bodily fluids for improved continence care that does not need to be removed
• Proven to protect the skin during vascular access care⁶. Compatible with chlorhexidine gluconate and povidone-iodine⁷
• Enables the fixation of roll plasters and bandages
• Peel-open packaging enables sterile removal of the applicator (applies to 3343)
• A proven solution: over 80 publications confirm its effectiveness and cost-effectiveness⁸ ⁹

Possible applications

• Prevention of IAD (incontinence-associated dermatitis)⁸
• Protection of the skin around stomas and drains⁸
• Protection of the wound environment⁸
• Prevention of skin injuries caused by medical adhesives (MARSI) in the area of vascular access, under adhesive dressings, roll plasters and negative pressure wound therapy (NPWT)⁸
• Protection against moisture and friction ¹⁰ (intertriginous dermatitis)

¹ 2010 Grove et al. 3M White Paper. A Comparison of the Durability of Four Barrier Film Products Over a 72 Hour Period on Human Volunteers. ² CLIN-RPT-FINAL-ICH3-US-05-155867 EM-05-012107 Study to Determine the Ability of the Carbon Black Retention Method to Assess the Durability of Film-Forming Agents, Sponsor Final report (2010). ³ Cameron J, Hoffman D, Wilson J, Cherry G. "Comparison of two peri-wound skin protectants in venous leg ulcers: a randomised controlled trial". J Wound Care, vol. 14, no. 5, 2005, pp. 233-236. ⁴ Rueda Lopez J, et.al. "A comparative study of a barrier product versus zinc oxide for the treatment of incontinent lesions". Oral presentation at the World Union Wound Healing Society (WUWHS) Meeting in Paris; 2004. ⁵ CLIN-RPT-FINAL-INV-US-05-289804 EM-05-013869 Study to Assess the Durability of Film-Forming Barriers Using the Activated Carbon Retention Method (2016). ⁶ CLIN-SUPPORT-05-863013 NSBF Clinical Evidence Summary Brochure (2022). ⁷ 3M Data on file. ⁸ CLIN-SUPPORT-05-863013 NSBF Clinical Evidence Summary Brochure (2022). ⁹ CLIN-MISC-US-05-333303 Additional Clinical Evidence for NSBF (2017). ¹⁰ CLIN-MISC-US-05-169008 NSBF Friction Study Grove (2011)

Dosage form

Applicator lollipops, sterile